GMA appoints food safety executive
WASHINGTON — The Grocery Manufacturers Association has named George Dunaif as its new VP food safety and technical services.
Dunaif most recently served as VP global food safety at Campbell Soup. In that role, he was responsible for the company’s worldwide food safety function, including toxicology, microbiology, process safety and analytical chemistry. He also served as vice-chairman of the Campbell corporate crisis management team.
“I am honored to join the GMA team,” Dunaif said. “The association plays an important leadership role when it comes to food safety, and I look forward to working with the GMA staff and the experts at its member companies to improve food safety in the U.S. and around the globe.”
M&M’s celebrates birthday of pretzel chocolate candies in New York
HACKETTSTOWN, N.J. — To celebrate the first birthday of its M&M’s pretzel chocolate candies, Mars Chocolate said it is looking to break the Guinness World Record for the largest piñata.
Hosted at the 69th Regiment Armory in New York on Thursday from 11:30 a.m. until 1 p.m., the celebration will feature a candy-filled, 46-ft. replica of the orange M&M’s spokescandy, which will release thousands of bags of M&M’s pretzel chocolate candies to visitors. An official from the Guinness Book of World Records will be on-site to verify the piñata as the largest ever constructed, Mars Chocolate said. Also on hand to celebrate the first birthday of M&M’s pretzel will be Grammy-award winner Cee Lo Green.
"When M&M’s pretzel was recently named the ‘Product of the Year,’ we knew we’d have to throw an unforgettable birthday bash," Mars Chocolate North America chief consumer officer Debra Sandler said.
Wockhardt divests nutrition business
MUMBAI, India — Indian generic drug maker Wockhardt will sell its nutrition business to France’s Danone, the company said Tuesday.
The deal is worth $355 million, according to published reports, and includes brands like Farex, Dexolac, Nusobee and Protinex.
Wockhardt said the deal was part of a strategy to consolidate and rationalize its core operations and focus on its pharmaceutical business.